Curis (CRIS) Tops Q2 EPS by 13c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq fall as megacap tech drags; Iran developments watched
- Oil falls 4% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
- Sanuwave cuts Q2 2026 revenue guidance amid Ultramist sales pressure
Curis (CRIS) PT Lowered to $6 at Baird
August 3, 2018 7:12 AM EDTBaird lowered its price target on Curis (NASDAQ: CRIS) to $6.00 (from $15.00) while maintaining an Outperform rating.
Analsyt Brian Skorney commented, "Curis announced 2Q18 earnings along with a pipeline update. The regulatory pathway for fimepinostat seems to be longer than... More
